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Abstract
Introduction: Patients with chronic obstructive pulmonary disease require help in daily life situations to increase their
individual perception of security, especially under worsened medical conditions. Unnecessary hospital (re-)admissions and
home visits by doctors or nurses shall be avoided. This study evaluates the results from a two-year telemedicine field trial
for automatic health status assessment based on remote monitoring and analysis of a long time series of vital signs data from
patients at home over periods of weeks or months.
Methods: After discharge from hospital treatment for acute exacerbations, 94 patients were recruited for follow-up by the
trial system. The system supported daily measurements of pulse and transdermal peripheral capillary oxygen saturation at
patients’ homes, a symptom-specific questionnaire, and provided nurses trained to use telemedicine (‘‘telenurses’’) with an
automatically generated health status overview of all monitored patients. A colour code (green/yellow/red) indicated whether
the patient was stable or had a notable deterioration, while red alerts highlighted those in most urgent need of follow-up. The
telenurses could manually overwrite the status level based on the patients’ conditions observed through video consultation.
Results: Health status evaluation in 4970 telemonitor datasets were assessed retrospectively. The automatic health status
determination (subgroup of 33 patients) showed green status at 46% of the days during a one-month monitoring period, 28%
yellow status, and 19% red status (no data reported at 7% of the days). The telenurses manually downrated approximately 10%
of the red or yellow alerts.
Discussion: The evaluation of the defined real-time health status assessment algorithms, which involve static rules with
personally adapted elements, shows limitations to adapt long-term home monitoring with adequate interpretation of day-to-
day changes in the patient’s condition. Thus, due to the given sensitivity and specificity of such algorithms, it seems challenging to
avoid false high alerts.
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Introduction
The remote home monitoring of patients with
chronic diseases has been a topic of many research pro-
jects.1–4 The main goals in these studies have been to help 
patients in daily life situations, to increase their individual
perception of security especially under worsened medical
conditions, to reduce home visits by doctors or nurses,
and to avoid unnecessary hospital admissions and
readmissions.
The analysis of a long time series of vital signs data
from patients at home over periods of weeks or months
is both a new opportunity as well as a new challenge for
healthcare services, and diﬀers from traditional
monitoring procedures in a hospital ward or under emer-
gency conditions. While classic triage procedures such as
‘‘trauma triage’’, ‘‘emergency triage’’, or ‘‘emergency
department (ED) triage’’5,6 are deﬁned as ‘‘the process
of classifying patients according to injury severity and
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determining the priority for further treatment’’, the long-
term follow-up of patients with chronic diseases has to
adapt the treatment and medication to the long-term
telemonitoring perception and short-term changes of the
condition of the individual patient and the corresponding
needs for support and intervention. To avoid confusion
between the objectives of clinical ‘‘ED triage’’ and those of
the long-term monitoring and decision support for treat-
ment and follow-up prioritisation of home-based patients,
the terms ‘‘health status level assessment’’ and ‘‘health
status score’’ will be used in this study.
Diﬃculties arise in the determination of actual algo-
rithms for automatic health status score calculations,
and in the deﬁnition of cut-oﬀ values for the diﬀerent
reported modalities to trigger the correctly colour-coded
alert level for such remote home monitoring situations.
In a review of 20 studies for predictive algorithms for
the early prediction of chronic obstructive pulmonary dis-
ease (COPD) exacerbations to support clinical decisions
of home telemonitoring, Sanchez-Morillo et al. concluded
that ‘‘models with good clinical reliability have yet to be
deﬁned’’, and that ‘‘novel predictors need to be identi-
ﬁed’’.7 In the UK, 12 telehealth systems were analysed
for their use of information exchange between patients
and healthcare professionals.8 Data analysis methods
with predeﬁned algorithms to be conﬁgured by the
health professionals were implemented in 11 of the sys-
tems. In four of the investigated systems, a colour-coded
format was used to indicate the severity of the patients’
status and the priority of support and follow-up; at the
same time, occasionally false positive and false negative
alerts were encountered.
For the detection of day-to-day variations of the
patient’s condition, it is not possible to use retrospective
methods; thus, methods for automated calculations of
individual threshold values will be necessary to develop.
But there seems to be a gap in the knowledge on how
patients in their daily routines use sensors for telemonitor-
ing, and which indicators might be used in which way for
triggering alerts that should, in turn, lead to appropriate
levels of responses.9
The results of this study should help to answer the
following research questions:
RQ 1. Do the implemented health assessment algorithms
provide the required adaptation of health status levels and
corresponding alerts for treatment and follow-up needs to
the individual medical condition of each COPD patient?
RQ 2. What recommendations can be given for improved
cut-oﬀ values and algorithms, or for procedures to deﬁne
or calculate appropriate values?
Methods
For the Norwegian trial in the EU-funded-project
‘‘United4Health’’ (U4H),10,11 a solution was developed
for COPD patients at home, involving a tablet personal
computer (PC) application to collect and transmit moni-
toring data, and a video conferencing tool to get support
from one of eight nurses trained to use telemedicine (‘‘tel-
enurse’’) at a telemedical centre.12–14 They were instructed 
to report their health symptoms daily (the patients were
asked to send their measurement data/symptom question-
naires in the morning, since COPD usually has the highest
symptom load at that time of day), followed up by a video
consultation where a telenurse explained necessary actions
like changes in inhalation therapy or the start of antibiotic
or corticosteroid treatment, or both, if a worsened situation
was encountered. (The telemedicine system for the collec-
tion and assessment of remote monitoring data was avail-
able 24/7. The support service by the telenurses was only
available during oﬃce hours of the telemedical centre
(Monday–Friday 8:00–15:00; Saturday 8:00–12:00).
Automatic alerts were only followed-up during oﬃce
hours, and patients were told to call their general practi-
tioners (GPs) or emergency services if they needed help
outside oﬃce hours.) The health status assessment included
measurements of the transdermal, peripheral capillary
oxygen saturation (SpO2) of the blood, and the heart rate
measured with a pulse oximeter connected via Bluetooth to
the tablet PC, and information about subjective symptoms
observed by the patient, as gathered through a daily elec-
tronic questionnaire (Table 1). Peak Expiratory Flow (PEF) 
measurements were skipped from the method section by the 
Table 1. Daily questionnaire.
Qi Question Possible answers
Q1 How do you feel today? As usual
Worse
Much worse
Q2 How is your breathing
today?
As usual
Worse
Much worse
Q3 How is your amount of
sputum today?
As usual
Worse
Much worse
Q4 What is the colour of your
sputum today?
No sputum/Clear/White
Yellow/Green/Brown
Q5 Are you using rescue
medication/nebuliser
or oxygen today?
No, I am not using them today.
As usual
More than usual
Much more than usual
Q6 Have you started up
with additional antibiotics
after last discharge?
No/I have finished.
Yes – Apocillin/Penicillin
Yes – Imacillin/Amoxicillin
Yes – Ciproxin
Yes – Azitromax
Yes -Other
Q7 Have you started up
with new Prednisolon
after last discharge?
No.
Yes – 20mg
Yes – 30mg
Yes – 40mg
Yes -Other
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U4H consortium since clinicians judged PEF to be 
unreliable during a COPD exacerbation. Reported data 
were instantly evaluated automatically when received 
from the patient, using an algorithm to create a colour 
code that provided the nurse with a quick overview of the 
latest patient condition.15
Patients hospitalised for exacerbation of COPD
(according to the Global Strategy for Diagnosis,
Management and Prevention of Obstructive Lung
Disease) were considered for inclusion at the time of dis-
charge from the pulmonary department at Sørlandet
Hospital HF in Kristiansand. The exclusion criteria com-
prised patients that did not want or could not sign the
informed consent form, were not able to or did not
want to use the telemedicine system, were in problematic
clinical or social circumstances, or were discharged to a
locality that either had no mobile broadband data cover-
age or could not be reached by the telemonitoring team.
A trained nurse instructed the patient in how to use the
telehealth solution, and the ﬁrst measurements of pulse
and SpO2 were recorded and used as reference values for
the following day-to-day monitoring data. Baseline data
were collected by the hospital staﬀ at discharge.
All data measured and reported by the patients with
their tablet PC application were consecutively uploaded to
a secured data server at the telemedical centre, where the
health status levels were automatically calculated with a
speciﬁc algorithm. The U4H protocol deﬁned cut-oﬀ
values for a ‘‘red’’ alert status based on already existing
empirical clinical basis and algorithms used in several cen-
tres in the UK. For the Norwegian trial, cut-oﬀ values for
a ‘‘yellow’’ health status were added to the clinical proto-
col by the study clinician (co-author of this paper) to
increase the sensitivity of the system and the patients’
safety as an early warning indicator of a ‘‘notable’’
health condition deterioration.
Green: The patient is in a stable or improved clinical
condition with unchanged medication. The self-reported
health symptoms are unchanged or improved compared to
the previous day. The reported pulse oximetry measure-
ments are within an acceptable range compared to indi-
vidual reference values.
Yellow: The patient is in a condition that needs special
attention. If the pulse oximetry measurements, or at least
one reported symptom, indicate notable deterioration
since the previous day or the hospital discharge, respect-
ively, a yellow alert is triggered. These cut-oﬀs were: an
increase in pulse of >10 bpm, a reduction in SpO2 of 4–
5%, an answer to question 1, 2, 3, or 4 deﬁned as ‘‘worse’’,
or question 5 answered with ‘‘more than usual’’ (Table 1).
Red: The patient is in a critical condition. The pulse
oximetry measurements or the self-reported symptoms
indicate signiﬁcant deterioration since the previous day
or hospital discharge, respectively; that is, an increase in
pulse of >15 bpm, a pulse of >120 beats/min or <50
beats/min, an oxygen saturation that is 56% lower
than the reference value, or Q5 answered with ‘‘much
more than usual’’.
Following the trial protocol, a daily teleconsultation
took place with all patients during the (typically) ﬁrst 14
days of trial participation (High Level of Telemonitoring
Service phase). For the next 14 days (Reduced Level of
Telemonitoring Service phase), the daily measurements
and symptoms reporting were continued, but a video con-
sultation would only be conducted in the case of a dete-
riorated health condition, indicated by yellow or red status
alert. After approximately one month the equipment
should be returned to the hospital, but the patients
could call the telemedical centre to discuss their condition
with the trained nurses at any time during the opening
hours for the next 11 months (Low Level of
Telemonitoring Service phase). If recommended by a
doctor, the High or Reduced Level of Telemonitoring
Service phases could be prolonged, resulting in situations
where patients could keep the equipment at home, to be
used in cases needed. After the teleconsultation, the tele-
nurses could manually overwrite (i.e. increase or decrease)
the automatically calculated health status assessment
levels, based on their experience with the health condition
of each individual patient, or following a discussion with
the patient’s GP.
To investigate the obtained accuracy of the automatic
health status assessment algorithms and the reasons for
any manual overwrites, we have analysed the monitoring
datasets from the clinical trial, with the aim of deﬁning
recommendations for improved algorithms for automatic
calculations of a health status score. The datasets were de-
identiﬁed and exported from the telemedicine system to
Excel spreadsheets for the evaluation of the health level
status assessment in this study.
Ethical considerations
This study was approved by the Norwegian Centre for
Research Data (project number: 35356). All participants
received oral and written information about the project
and conﬁdential treatment of the collected data.
Participation was voluntary and participants could with-
draw at any time without reason. All participants gave
explicit written consent.
Results
During a period of two years, from May 2014 to April
2016, a total of 94 patients with COPD were recruited for
the telemonitoring trial. (The trial system had been in
operation until June 2016, but monitoring data and auto-
matic assessments after April 2016 could not be con-
sidered for this study.) The baseline data are listed in
Table 2. Approximately 2%, 19%, 32%, and 44% were
in COPD stage I, II, III, and IV, respectively.
The planned participation duration of each patient in
the trial according to the clinical trial protocol was 30
days after discharge from hospital, but with wide possi-
bilities for personal adaption as recommended by the
doctors, leading to some earlier drop-outs, and some
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cases of signiﬁcant longer participation. Approximately
10% of the patients were readmitted to hospital and
thus had 2–3 additional periods of telemonitoring. Two
thirds of the patients had a prolonged use of the tele-
monitoring services beyond the planned 30 days, and
more than a quarter kept the equipment and reported
monitoring data for more than 90 days. Approximately
one third of the patients were deﬁned as drop-out before
the end of the planned period for diﬀerent reasons (e.g.
some of them encountered diﬃculties with bad quality in
the video consultations due to poor mobile data cover-
age). The number of days included in the telemonitoring
trial (taken from the last day of monitoring data
reported to the telehealth system) varied from 1 to
more than 365 (Figure 1), and the overall average dur-
ation of participation in the telemonitoring services was
70 days.
In total, 4970 datasets were analysed for this study
received by the telehealth system, each containing a pair
of pulse oximetry measurements (pulse and SpO2), a set of
answers to the daily questionnaire, or a combination of
both. There could be multiple datasets for one patient for
one day; for example, in case the measurement or the
questionnaire had been executed and transmitted multiple
times, or as a consequence of suggested repeated monitor-
ing during a deterioration. For the health status level
assessment, the ﬁrst reported data of the day is used, as
the result potentially triggers an alert to the telenurses for
required follow-up support or treatment.
An overview of the development of the pulse oximetry
data (measurements of pulse and SpO2) reported by the
patients during the ﬁrst 90 days of their trial involvement
is shown in Figure 2. More than two thirds of the patients
that still had the monitoring equipment sent their reports
(e.g. 94%, 75%, 63%, and 67% on day 1, 30, 60, and 90,
respectively).
The average daily reporting rate is illustrated in
Figure 3. As long as the patients had the monitoring
equipment, they used it on average for at least 70% of
the days (Monday–Friday) to send monitoring data.
They sent pulse-oximetry measurements at an average of
75% of the days during the ﬁrst 30 days, and daily ques-
tionnaires 84% of the days. During the 90-day period,
monitoring data were sent at two thirds of the days (i.e.
at 60 days in average).
For the accuracy analysis of the health status assess-
ment algorithm we have selected a subgroup of 33 patients
(i.e. 35% of the total of 94 patients), that have reported
pulse oximetry measurements and/or answers to the daily
questionnaire on a minimum of 25 days during the ﬁrst 30
days of participation in the telemonitoring trial.
The automatic health status level categorisation into
‘‘green’’, ‘‘yellow’’, and ‘‘red’’ alerts were assessed before
they were analysed and possibly overwritten by the tele-
nurses. Monitoring 33 patients over 30 days corresponds
to a total of 990 ‘‘patient-reporting days’’, of which we
received 928 reported datasets (94%). In total, 460
patient-reporting days (46%) were assessed as ‘‘green’’
level (indicating a stable condition of the patient on that
day), 275 (28%) as ‘‘yellow’’ (alerting the nurse of a
notable condition), and 193 (19%) as ‘‘red’’ level. The
frequency of each health status level (averaged over all
patients and all days of the considered periods) is illu-
strated in Figure 4.
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Figure 1. Histogram of participation duration (number of days) in telemedicine trial (n¼ 94).
Table 2. Baseline data of patients included in telemonitoring trial.
Male (n¼ 48) Female (n¼ 46) Total (n¼ 94)
Mean SD Mean SD Mean SD
Age 70.7 9.4 67.6 8.8 69.2 9.2
FEV1 in %
predicted
38.2 17 38.1 12.5 38.1 14.8
SD: standard deviation.
4 Journal of Telemedicine and Telecare 0(0)
In total, 101 assessments (i.e. 10% of all 990 ‘‘patient
days’’) were modiﬁed manually by the telenurses, 81%
were unchanged, and 9% were incomprehensible to
assess due to lack of reported data. An overview of the
type of the adjustments and the reasons is given in
Table 3: if the reported data, such as a pulse value,
caused a red or yellow alert, and the telenurse adjusted
the corresponding initial health status assessment level
following the video consultation, because the health con-
dition was actually not critical, the health status level was
lowered to yellow or green, respectively, and the data was
counted as ‘‘initial pulse assessment too high’’. In total,
10% of the calculated health status levels were downrated
and thus could be judged as false positive if the reclassiﬁ-
cation at the telemedical central, including manual over-
writes by the telehealth nurses, was considered correct.
0 %
10 %
20 %
30 %
40 %
50 %
60 %
70 %
80 %
90 %
100 %
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
1 5 9 13 17 21 25 29 33 37 41 45 49 53 57 61 65 69 73 77 81 85 89
Pe
rc
en
ta
ge
of
 p
  t
ha
t s
en
t p
ul
se
-o
xi
m
et
ry
 d
at
a
Percentage of paents that sent pulse-oximetry data
Sp
O
2
[ %
 ] 
an
d 
Pu
lse
 [b
ea
ts
 p
er
 m
in
]
Re day in the monitoring program
SpO2-average Pulse-average
Figure 2. Development of reported pulse and blood-oxygen saturation (SpO2) (n¼ 94).
Percentage of patients that sent measurement report (green line, right y-axis); average pulse and SpO2 values (calculated each day from all
received patient reports) together with their minimum and maximum values (blue and red line respectively, scale of left y-axis for both
parameters).
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Figure 3. Average reporting rate (% of days reported) (n¼ 94).
Percentage of days during first 7, 14, 30, 60, and 90 days when monitoring data was sent.
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Of those, pulse assessment (42%) and daily questionnaire
assessment (39%) were the main reasons for too-high
assessment-level calculation.
Discussion
The examined trial system facilitates the remote monitor-
ing of home-based COPD patients and the provision of
decision-support information for the prioritisation
of follow-up support and treatment by telenurses in a
telemedical centre, in cooperation with GPs and medical
specialists in hospitals. Changes of certain monitoring
data from one day to the next are important to identify
notable or even critical exacerbations.
Patients reported monitoring data regularly every
weekday and partially beyond that during the weekend.
Technical problems or diﬃculties to use the equipment for
collecting or sending the data could obviously be avoided
by involving the patients in a user-centred design pro-
cess.12 A potential reason for incomplete reporting data
(in particular, in the case of long-term routine monitoring)
was a good individual perceived health condition, leading
to a lower support need and the impetus to report health
data. Hence, the lack of monitoring data does not neces-
sarily indicate a bad or even alert condition, but may indi-
cate the opposite; that is, a stable or improved health
status. However, with the current algorithms of the
telehealth service these aspects are diﬃcult to interpret.
If the overall health condition of a patient is unknown
or unstable, the lack of monitoring data should preferably
trigger an alert to follow-up with a remote check-up of the
patient (e.g. by phone or video call) or with a reminder to
send monitoring data. If a patient condition is known and
overall stable, the lack of data for one or a few days can be
treated diﬀerently, usually assuming no signiﬁcant
changes in the health condition. This, in turn, requires a
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Figure 4. Unadjusted average health status level during selected monitoring periods (n¼ 33).
Table 3. Analysis of manual overwrites of health status level assessment.
Type of adaptation (related to all assessments) Reasons for adaptation (related to overwrites)
False-high Red to yellow 2.7% Initial pulse assessment too high 41.6%
Yellow to green 5.3% Initial SpO2 assessment too high 4.0%
Red to green 1.7% Initial pulse and SpO2 assessment too high 3.0%
Initial daily questionnaire assessment too high 38.6%
Initial pulse and daily questionnaire assessment too high 7.9%
Sum 9.7% Sum 95.0%
False-low Green to yellow 0.4%
Yellow to red 0.1%
Green to red 0.0%
Sum 0.5% All initial assessment levels too low 5.0%
Total 10.2% Total 100%
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system that can ascertain the behavioural characteristics
of a patient, and that can identify a good, healthy, stable
condition and distinguish that from a condition in
deterioration.
The health status of the monitored patients is – on
average – quite constant during the trial period. The mea-
sured pulse oximetry data (Figure 2) does not show sig-
niﬁcant mean changes during the ﬁrst 90 days, while
extreme values (as extreme high, low pulse or very low
SpO2 measurements) become less frequent with increasing
monitoring duration (i.e. beyond day 60). The clinical
expectation here would be an increased SpO2 and reduced
pulse over time due to improved clinical conditions during
monitoring. Certainly, the reduced number of participat-
ing patients causes a selection bias here that cannot be
corrected and may explain why values (Figure 2) seem
stable. Thus, patients that experience an improved condi-
tion may, to a larger degree, drop out of monitoring com-
pared to those who are deteriorating or experience
continued exacerbation. Beyond day 70, however, the
number of higher maximum values of the score increases,
indicating a ‘‘worse’’ or even ‘‘much worse’’ subjective
health perception of some patients, most likely also inﬂu-
enced by a selection bias of those with a more chronically
unstable condition.
The assessment of the pulse and especially the SpO2
measurements was of essential importance for the moni-
toring of the COPD status. The introduction of a ‘‘yellow
alert’’ allowed the nurses to detect early deteriorations of
COPD that, assuming sound handling, could avoid more
serious deteriorations and unnecessary hospitalisations. In
the PROMETE study4 a three-colour traﬃc light system
was used, but only the red alert was related to the patient’s
measurements.
The manual overwriting of the automatic health status
level assessment by the telenurses resulted in adjusted
health status levels. The analysis of the adjustments
(Table 3) shows that approximately one in 10 of all assess-
ment levels were set lower by the nurses, and mainly from
‘‘yellow’’ to ‘‘green’’. In most of these cases, either the
initial assessments of the measured pulse values were too
high, or of single items of the daily questionnaire. The
cut-oﬀs had been deﬁned accurately according to general
clinical knowledge and the U4H trial protocol, and
provided adaptation to the patients’ condition through
individual reference values taken on the day of discharge
from the hospital. However, high pulse could be detected
if the patient had been in activity just before monitoring
the pulse. In such cases, a retest of the pulse after 5–10min
(e.g. during a video consultation) often showed a lower
pulse so that the initial red alert was adapted to yellow,
and yellow to green. Thus, the automatic assessment by
the telehealth service based on generic, static cut-oﬀ values
might be too sensitive and not suﬃciently personalised for
each individual patient, causing unnecessary warnings or
alerts. In a COPD pilot monitoring study, Velardo et al.2
used multivariate analyses and non-parametric density
estimation techniques for calculations of the actual
threshold values. Shah et al.3 found (in the same pilot
study) advantages of including respiratory rate as a
predictor in the multivariate approach, giving improved
estimations for personalised alerts. Farmer et al.1 used a
95th centile as the alert threshold for heart rate and
oxygen saturation, and Segrelles Calvo et al.4 calculated
an average value over measurements from the ﬁrst three
consecutive days as baseline for the calculation of devi-
ations causing alerts.
Improved algorithms for automatic calculations of a
health status score will be of importance for the routine
use of telehealth solutions to support the self-management
of patients with COPD. Improved algorithms are also
relevant in systems for telenurses to assist patients with
correct medical advises. An approach for ongoing
research work would be the utilisation of smart, self-learn-
ing systems with artiﬁcial intelligence (AI) technologies.
The development of appropriate machine learning
algorithms and corresponding real-time data evaluation
systems requires more clinical data.
Related studies evaluating the clinical outcome of the
interventions by the telenurses triggered by the alerts
during this trial are under publication.
Conclusions and lessons learned
The automatic, computer-based assessment of monitoring
data from home-living COPD patients, as explored in this
trial system, utilises algorithms and rules that depend on
cut-oﬀ values for certain measurements or self-reported
parameters, thereby reﬂecting the health condition of the
patients. As such algorithms and rules look at the day-to-
day development and changes of the reported data to
identify notable or critical abnormalities, the accuracy
and reliability of the health status assessments depend
highly on the continuous reporting of the required param-
eters by patients, at least on a daily or more frequent,
regular basis. This study reveals that there were no tech-
nical problems or usability challenges causing signiﬁcant
interruptions of the self-reporting of monitoring data by
the patients, but that a stable and improving subjective
health and well-being status could lead to a reduced
motivation to regularly report health data.
Furthermore, the cut-oﬀ values deﬁning certain health 
status levels are crucial for the accuracy of the health 
status assessment, and thus for the quality of the rule-
based analysis. The results from the trial system show 
that static, generic cut-oﬀ values, as used, for example, 
for emergency medicine triage, are suﬃcient to trigger 
emergency alerts, while they do not support decisions by 
telenurses with high accuracy and reliability. Instead, cut-
oﬀ values must be personalised to the indi-vidual health 
condition and common levels of health par-ameters. 
Predetermined, personally adapted cut-oﬀ values deﬁned 
at the beginning of a telehealth monitoring period of a 
patient might not adapt suﬃciently with the dynamic 
general health condition of a patient. The results from the 
tested algorithms are not suﬃcient to provide for reliable
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(avoiding false-negative) and eﬃcient (avoiding false-
positive) alerts. More personalised, adaptive, and intelli-
gent assessments are needed.
The tested telehealth trial system has shown strengths
and advantages in the patient interaction, data collection,
timely, reliable, and safe transmission of monitoring data,
and the interaction with health professionals. Ongoing
research work will combine, test, and evaluate this in com-
bination with smarter, AI-based assessment and decision-
support algorithms.
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